KT-Biologics I (KTB1): A Dynamic Simulation Model for Continuous Biologics Manufacturing

Mohammad Reza Boskabadi,Pedram Ramin,Julian Kager,Gürkan Sin,Seyed Soheil Mansouri
DOI: https://doi.org/10.1016/j.compchemeng.2024.108770
IF: 4.13
2024-06-16
Computers & Chemical Engineering
Abstract:The pharmaceutical industry's shift towards biological therapeutics has led to a transition from conventional batch production to continuous manufacturing. This change highlights the crucial need for effective process monitoring and control strategies to ensure consistent product quality and stability. Open-source benchmark simulation models have become essential tools for refining these processes, offering a platform for testing research hypotheses. This study uses the production of Lovastatin as a case study for continuous biopharmaceutical production. A comprehensive dynamic model covering upstream and downstream components provides an integrated perspective of the production process. The study introduces a basic control system emphasizing realistic sensor and actuator integration to enhance simulation accuracy. It assesses the benchmark through open-loop and closed-loop simulations, offering an in-depth analysis of the KTB1 model's dynamic response and functionality. KTB1 represents a model-driven decision support tool that enables the evaluation of monitoring strategies, process design, process optimization, and control for biomanufacturing.
engineering, chemical,computer science, interdisciplinary applications
What problem does this paper attempt to address?